What does 2019 hold for biotech? This was my question to Irina Haivas, Principal at Atomico. We chat about the evolution of the biotech space in 2018; how and why investors with more digital backgrounds are moving in; and which companies, funds and conferences she’ll be keeping her eye on in 2019.